FMNL1 and cancer: FMNL1 expression was positively correlated with the T-cell inflamed score, an alternative indicator to evaluate the clinical response to immunotherapy, and the activities associated with most steps of cancer immunity cycle were significantly upregulated in the high FMNL1 group (Supplementary Figure S1C-D).